» Articles » PMID: 29801418

Rare-Variant Studies to Complement Genome-Wide Association Studies

Overview
Publisher Annual Reviews
Specialty Genetics
Date 2018 May 27
PMID 29801418
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-wide association studies (GWASs) have revolutionized human disease genetics by discovering tens of thousands of associations between common variants and complex diseases. In parallel, huge technological advances in DNA sequencing have made it possible to measure and analyze rare variation in populations. This review considers these two stories and how they have come together. We first review the history of GWASs and sequencing. We then consider how to understand the biological mechanisms that drive signals of strong association in the absence of rare-variant studies. We describe how rare-variant studies complement these approaches and highlight both data generation and statistical challenges in their interpretation. Finally, we consider how certain special study designs, such as those for families and isolated populations, fit in this paradigm.

Citing Articles

Assessment of the functionality and usability of open-source rare variant analysis pipelines.

Riccio C, Jansen M, Thalen F, Koliopanos G, Link V, Ziegler A Brief Bioinform. 2025; 26(1).

PMID: 39907318 PMC: 11795309. DOI: 10.1093/bib/bbaf044.


Low-frequency variants in genes involved in glutamic acid metabolism and γ-glutamyl cycle and risk of coronary artery disease in type 2 diabetes.

Giuffrida F, Rai S, Tang Y, Mendonca C, Frodsham S, Shah H Cardiovasc Diabetol. 2024; 23(1):406.

PMID: 39538235 PMC: 11562816. DOI: 10.1186/s12933-024-02442-5.


Rare and common variants associated with alcohol consumption identify a conserved molecular network.

Leger B, Meredith J, Ideker T, Sanchez-Roige S, Palmer A Alcohol Clin Exp Res (Hoboken). 2024; 48(9):1704-1715.

PMID: 39031522 PMC: 11576244. DOI: 10.1111/acer.15399.


Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidation.

Wang G, Xu Y, Wang Q, Chai Y, Sun X, Yang F Fundam Res. 2024; 2(6):918-928.

PMID: 38933382 PMC: 11197726. DOI: 10.1016/j.fmre.2022.09.002.


NRDE2 deficiency impairs homologous recombination repair and sensitizes hepatocellular carcinoma to PARP inhibitors.

Wang Y, Liu X, Zuo X, Wang C, Zhang Z, Zhang H Cell Genom. 2024; 4(5):100550.

PMID: 38697125 PMC: 11099347. DOI: 10.1016/j.xgen.2024.100550.